APRICOXIB Cyclooxygenase-2 (COX-2) Inhibitor Oncolytic

被引：0
|
作者：
Edelman, Martin J. [1 ]
机构：
[1] Univ Maryland, Greenebaum Canc Ctr, Baltimore, MD 21201 USA
来源：
DRUGS OF THE FUTURE | 2011年 / 36卷 / 07期
关键词：
CS-706; R-109339; TG-01; TP-1001; TP-2001; METASTATIC BREAST-CANCER; CELL LUNG-CANCER; DOUBLE-BLIND; CARDIOVASCULAR EVENTS; COVALENT BINDING; PHASE-II; CELECOXIB; EXPRESSION; ROFECOXIB; CS-706;
D O I：
10.1358/dof.2011.036.07.1608943
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Overexpression of cyclooxygenase-2 (COX-2) has been implicated as a tumor-initiating and -promoting event for a number of common solid tumors, including lung, breast and colon cancer. Considerable epidemiological evidence supports COX-2 inhibition as a method of chemoprevention. Inhibition of COX-2 in laboratory models has been demonstrated to be antineoplastic both by itself and in combination with cytotoxic and targeted agents. Apricoxib is a novel, potent and selective inhibitor of COX-2 currently under development as an anti-cancer agent, as well as an analgesic. This review discusses the pharmacology, preclinical and clinical results with apricoxib, focusing on its potential use in oncology.
引用
收藏
页码：503 / 509
页数：7
相关论文
共 50 条
  • [1] Cyclooxygenase-2 (COX-2) inhibitor stimulates pancreatic cancer growth
    Eibl, G
    Reber, HA
    Wente, MN
    Hines, OJ
    GASTROENTEROLOGY, 2002, 122 (04) : A489 - A490
  • [2] Cyclooxygenase-2 (COX-2) in acute myocardial infarction: cellular expression and use of selective COX-2 inhibitor
    Saito, T
    Rodger, I
    Shennib, H
    Hu, F
    Tayara, L
    Giaid, A
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2003, 81 (02) : 114 - 119
  • [3] Cyclooxygenase-2 (Cox-2) in Newborn Lung
    P Lassus
    H Wolff
    S Andersson
    Pediatric Research, 1999, 45 (6) : 887 - 887
  • [4] Expression of cyclooxygenase-2(COX-2) in the retina and the effect of COX-2 inhibitor on the mouse model of retinopathy of prematurity
    Kim, CS
    Lee, SN
    Kim, JH
    Park, CJ
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46
  • [5] Cancer and cyclooxygenase-2 (COX-2) inhibition
    Evans, JF
    Kargman, SL
    CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (06) : 627 - 634
  • [6] Cyclooxygenase-2 (Cox-2) expression in lymphomas
    Hazar, B
    Ergin, M
    Seyrek, E
    Erdogan, E
    Tuncer, I
    Hakverdi, S
    LEUKEMIA & LYMPHOMA, 2004, 45 (07) : 1395 - 1399
  • [7] Cyclooxygenase-2 (COX-2) expression in retinoblastoma
    Mendez, MC
    Fernandes, L
    Caissie, AL
    Callejo, SA
    Burnier, MN
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2002, 43 : U605 - U605
  • [8] Cyclooxygenase-2 (COX-2) in newborn lung
    Lassus, P
    Wolff, H
    Andersson, S
    PEDIATRIC RESEARCH, 1999, 45 (06) : 887 - 887
  • [9] Glycosylation of cyclooxygenase-2 (COX-2) influences effectiveness of COX-2 inhibitors
    Graham, Kamara Whitney
    Sevigny, Mary B.
    Gabriel, Bianca S.
    FASEB JOURNAL, 2009, 23
  • [10] Modification of cyclooxygenase-2 (COX-2) inhibitor potency by lipid hydroperoxide (ROOH).
    Quellet, M
    Claveau, D
    Guay, J
    Riendeau, D
    Percival, MD
    FASEB JOURNAL, 2000, 14 (08): : A1522 - A1522
12345